Galectin Therapeutics shares owned by Boothbay Fund Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Boothbay Fund Management
from 13F filings
Historical chart of Boothbay Fund Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Galectin Therapeutics by Boothbay Fund Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $804k | 292k | 2.75 |
2021-06-30 | $35k | 11k | 3.19 |
2019-03-31 | $78k | 15k | 5.09 |
2018-12-31 | $105k | 31k | 3.44 |
2016-06-30 | $28k | 19k | 1.49 |
2016-03-31 | $27k | 19k | 1.43 |
2015-12-31 | $21k | 13k | 1.66 |